Statements (78)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:clinical_trial |
gptkb:Europe
gptkb:Asia gptkb:North_America Multiple Countries Phase 1 Phase 2 Phase 3 Cancer Vaccines Metastatic Cancer Various Cancer Types |
| gptkbp:collaborated_with |
Pharmaceutical Companies
Regulatory Agencies International Research Teams Patient Advocacy Groups Translational Research Projects |
| gptkbp:collaborations |
gptkb:Cancer_Research
Various Academic Institutions Biotech Firms |
| gptkbp:counseling_services |
Solid Tumors
|
| gptkbp:developer |
Novel Therapeutics
Next-Generation Cancer Treatments |
| gptkbp:develops |
Therapeutics
|
| gptkbp:explores |
Combination Therapies
|
| gptkbp:focuses_on |
gptkb:Cancer_Immunotherapy
Personalized Medicine |
| gptkbp:founded |
gptkb:2014
|
| gptkbp:grants |
National Institutes
|
| gptkbp:has_part |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:has_product |
Cancer Therapies
|
| gptkbp:headquarters |
gptkb:Liechtenstein
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aduro Biotech Liechtenstein
|
| gptkbp:innovation |
gptkb:healthcare_organization
Biopharmaceuticals Cancer Treatment Technologies |
| gptkbp:invention |
Biotechnology Innovations
|
| gptkbp:is_active_in |
Regenerative Medicine
|
| gptkbp:is_engaged_in |
Drug Development
|
| gptkbp:is_involved_in |
Clinical Research
|
| gptkbp:is_known_for |
Innovative Cancer Treatments
|
| gptkbp:is_part_of |
Global Biotech Community
|
| gptkbp:is_recognized_for |
Scientific Contributions
|
| gptkbp:is_studied_in |
Cancer Biomarkers
Immune Evasion |
| gptkbp:is_supported_by |
Government Grants
|
| gptkbp:key_people |
Stephen A. Isaacs
|
| gptkbp:located_in |
gptkb:Europe
|
| gptkbp:notable_allies |
Healthcare Organizations
|
| gptkbp:offers |
Immuno-oncology therapies
|
| gptkbp:operates_in |
gptkb:Pharmaceutical_Industry
|
| gptkbp:participated_in |
Global Health Initiatives
|
| gptkbp:partnerships |
Research Institutions
Clinical Research Organizations |
| gptkbp:receives_funding_from |
Venture Capital Firms
Private Investors |
| gptkbp:research |
gptkb:Tumor_Microenvironment
gptkb:healthcare_organization gptkb:vaccine Cancer Prevention Tumor Immunology Cancer Immunology Cellular Therapies Cancer Genetics Cancer Treatment Strategies Therapeutic Vaccines Oncogenic Pathways Tumor Antigens |
| gptkbp:research_and_development |
Solid Tumors
Rare Cancers |
| gptkbp:research_focus |
gptkb:Hematologic_Malignancies
Immune Response Modulation |
| gptkbp:stock_exchange |
gptkb:battle
|
| gptkbp:technology |
Cyclic dinucleotide platform
|
| gptkbp:utilizes |
Advanced Biologics
|
| gptkbp:website |
www.adurobiotech.com
|
| gptkbp:bfsParent |
gptkb:Aduro_Biotech,_Inc.
|
| gptkbp:bfsLayer |
5
|